ÂÜÀòÂÒÂ×

Shannon Strom has a strong background in regulatory affairs, with experience spanning over 15 years. Shannon has held various leadership positions in reputable pharmaceutical companies.

From 2005 to 2010, Shannon worked at Cato Research, initially as a Senior Regulatory Scientist and later as an Associate Director of Regulatory Operations. In these roles, they managed regulatory operations, including the creation and management of budgets, efficient submission processes, and document management. Shannon also served as a project manager for multidisciplinary teams, overseeing FDA meetings and managing regulatory submissions.

From 2010 to 2018, Shannon joined Pearl Therapeutics as a Director of Regulatory Affairs. Shannon subsequently assumed the role of Senior Director, overseeing global regulatory strategy development, execution, and submissions. Shannon demonstrated proficiency in leading an innovative regulatory affairs team and contributed to the company's success in drug development.

In 2018, Shannon moved to Roivant Sciences, where they served as a Senior Director of Global Regulatory Affairs. Shannon'sresponsibilities included developing and implementing global regulatory strategies for innovative medicines and ensuring timely submission of high-quality documentation to regulatory agencies. Shannon played a crucial role in aligning policies and procedures with industry guidelines and corporate objectives.

Currently, Shannon holds the position of Vice President and Head of Regulatory Affairs at Satsuma Pharmaceuticals, Inc. Since 2018, they have been leading the development and execution of global regulatory strategies for combination products. Shannon'srole involves interacting and negotiating with regulatory agency personnel to expedite approval of registrations and ensure strategic product direction to the organization.

Throughout their career, Shannon has consistently demonstrated their expertise in regulatory affairs, clinical development, and project management. Shannon is highly regarded for their dedication, professionalism, and ability to achieve success in complex regulatory environments.

Shannon Strom holds a Ph.D. in Pharmacology, which was obtained from the University of North Carolina at Chapel Hill. This degree was pursued from 1999 to 2005. Prior to that, Shannon completed a Bachelor of Science (B.S.) in Biology at Duke University, attending from 1994 to 1998.

In terms of additional certifications, Shannon obtained the United States Regulatory Affairs Certification from the Regulatory Affairs Professionals Society (RAPS) in 2005. Moreover, in 2015, Shannon obtained the European Union Regulatory Affairs Certification, also from RAPS. However, the specific months of attainment for both certifications were not provided.